Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,240 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

NCT05703516

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View Trial Details
Recruiting

UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance

NCT06726720

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Aix-en-Provence, France
  • Research Site Angers, France
  • Research Site Aurillac, France
  • Research Site Auxerre, France
View all 52 locations
View Trial Details
Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

NCT07531095

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • New York University Cancer Institute New York, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • Next Virginia Fairfax, Virginia, United States
  • Adana Sehir Egitim ve Arastirma Hastanesi Adana, Turkey (Türkiye)
View Trial Details

Related conditions